Psychiatric Centre Rigshospitalet
11
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
9.1%
1 terminated/withdrawn out of 11 trials
87.5%
+1.0% vs industry average
0%
0 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
Role: lead
Reducing the Rate and Duration of Re-ADMISsions Among Patients With Unipolar Disorder and Bipolar Disorder Using Smartphone-based Monitoring and Treatment - The RADMIS Trials
Role: lead
Virtual Reality-Assisted Cognitive Behavioral Therapy for Alcohol Dependence (CRAVR)
Role: lead
Virtual Reality-Assisted Cognitive Behavioral Therapy for Alcohol Dependence (CRAVR-Pilot)
Role: lead
Seasonal Affective Disorder and Visual Impairment
Role: lead
Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 Diabetes
Role: collaborator
Effects of Ketone Bodies on Cognition in Type 2 Diabetes
Role: collaborator
Daily Subjective and Objective Smartphone Measures of Illness Activity to Treat Bipolar Disorder- The MONARCA II Trial
Role: lead
Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?
Role: lead
The MONARCA Project (MONitoring, treAtment and pRediCtion of bipolAr Disorder Episodes)
Role: lead
KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment
Role: lead
All 11 trials loaded